from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3852/hns

LFCtreatmentdescriptionclass of inhibitor

0.929

Amikacinug/mL Amikacintranslation

0.847

Cap5-10ug/mL Capreomycintranslation

-0.184

Rox10-50 ug/mL Roxithromycintranslation

0.546

SM2-5 ug/mL Streptomycintranslation

0.289

Tet5-10 ug/mL Tetracyclinetranslation

-1.496

Rif0.2-5ug/mL Rifampicintranscription

-1.529

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.306

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.586

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.338

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.252

Clofazimine10-13 ug/mL Clofaziminerespiration

0.173

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.012

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.638

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.336

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.499

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.733

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.577

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.700

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.258

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.797

KCN5-20 ug/mL Potassium cyaniderespiration

1.675

NaN30.2-2 mM Sodium aziderespiration

0.133

Nigericin50 uM Nigericinrespiration

-0.645

TRC10-150 ug/mL Triclosanrespiration

-0.663

TRZ10-25 ug/mL Thioridazinerespiration

-0.866

Valinomycin0.5-10 uM Valinomycinrespiration

1.231

ZnSO42 mM ZnSO4respiration

-0.316

menadione6-10 ug/mL Menadionerespiration

-0.441

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.131

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.733

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.714

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.294

NRP_1Non-replicating persistence stage 1dosRassociated

0.559

Amp0.2mg/mL AmpicillincellWall

0.099

Cephalexin20-100 ug/mL CephalexincellWall

0.433

Cerulenin0.32-5 ug/mL CerulenincellWall

0.188

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.508

EMB10-20 ug/mL EthambutolcellWall

1.606

Eta12-40 ug/mL EthionamidecellWall

1.533

INH0.2-0.4 ug/mL IsoniazidcellWall

0.918

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.406

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.440

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.828

BZA0.12 mg/mL BenzamidearomaticAmides

0.153

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.226

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.987

H2O24 mM hydrogen peroxideDNAdamaging

-0.643

Levo10 ug/mL LevofloxacinDNAdamaging

0.594

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.483

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.139

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.217

UVUV-irradiationDNAdamaging

-1.169

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.158

Antimycin12.5-50 ug/mL Antimycin A?

0.119

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.451

PA_110-50 ug/mL Antitubercular compound PA-1?

0.380

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.987

PA8240.2-2 ug/mL PA-824?

-2.552

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.901

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.111

Verapamil50 uM Verapamil?

0.519

mercaptoethanol2 mM 2-Mercaptoethanol?

0.096

methoxatin10-20 ug/mL Methoxatin?